Canada: For Your Phase 3 Global Trial Expansion
Oncology continues to be the largest and fastest growing therapeutic area in the clinical trials market, and a market dominated…
Oncology continues to be the largest and fastest growing therapeutic area in the clinical trials market, and a market dominated…
With agility increasingly becoming the most important global driver of success, it’s worth noting that Canadian oncology research center Phase…
It’s worth your time to consider whether or not the commonly held belief that using a larger CRO for your…
It’s no surprise that an underperforming site can cause significant delays in meeting important accrual targets, data timelines, or study…
The Global Clinical Trials Market was valued at $44.3B USD in 2020, and by 2028 is expected to reach $69.3B…
Monitoring the progress of clinical research is fundamental to obtaining successful outcomes because it ensures that constraints to success are…
The COVID-19 pandemic has required the clinical research industry to find new and innovative ways to monitor investigative sites. Although…
Canada is considered one of the most attractive places to live in the world, with a high quality of life,…
Pre-pandemic oncology was both the largest and fastest growing therapeutic area in the clinical trials market. A key market trend…
Participant diversity in clinical trials can be quite challenging to achieve. With COVID the concern about appropriate demographic representation is…